Development of a risk assessment model for multimorbidity of diabetes, hypertension, and coronary heart disease with XGBoost in primary care in Shanghai, China: a retrospective study

基于XGBoost在上海基层医疗机构中构建糖尿病、高血压和冠心病多重合并症风险评估模型:一项回顾性研究

阅读:3

Abstract

BACKGROUND: Multimorbidity has emerged as a growing global health concern. Within its heterogeneous patterns, the cardiometabolic cluster is notably among the most common. Assessing the risk of such multimorbidity from a general practice perspective has become a priority in primary care. This study aimed to develop a comprehensive risk assessment model for the multimorbidity of diabetes, hypertension, and coronary heart disease among older adults in the community, utilizing large-scale data from Shanghai, China. METHODS: Retrospective data spanning 2017 to 2019 were collected from 40,261 residents across 47 community health centers. These data comprised residents' health records, health examination results, hospital information system (HIS) records, imaging databases, and lifestyle information. The XGBoost machine learning algorithm was utilized to construct a comprehensive risk assessment model for the multimorbidity of diabetes, hypertension, and coronary heart disease. Model performance was evaluated using the area under the receiver operating characteristic curve, accuracy, precision, recall, and the F1 Score. RESULTS: The dataset was split into training (80%) and testing (20%) sets. A total of 46 features were incorporated into the final comprehensive risk assessment model for the multimorbidity of diabetes, hypertension, and coronary heart disease. The optimal XGBoost model achieved a micro-average AUC of 0.822, a macro-average AUC of 0.795, and a weighted-average AUC of 0.784. These parameters demonstrate the high superiority of the constructed model. CONCLUSIONS: The XGBoost-based risk assessment model for the multimorbidity of diabetes, hypertension, and coronary heart disease, integrated clinical and public health data from community residents. It identifies multidimensional predictors across four dimensions, underscoring its practical value in supporting integrated risk assessment and informing targeted health management strategies for individuals with multimorbidity. CLINICAL TRIAL NUMBER: Not applicable.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。